Intranasal drug delivery device
Latest JANSSEN PHARMACEUTICA NV Patents:
- SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS
- 5-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide derivatives useful as a factor XIa inhibitors
- BENZIMIDAZOLES AS MODULATORS OF IL-17
- Compounds and uses thereof
- System and method for detecting cognitive decline using speech analysis
Description
Claims
The ornamental design for an intranasal drug delivery device, as shown and described.
Referenced Cited
U.S. Patent Documents
D308100 | May 22, 1990 | Bishop |
D401323 | November 17, 1998 | Ritsche |
D433123 | October 31, 2000 | Sheppard |
D433124 | October 31, 2000 | Sheppard |
D471973 | March 18, 2003 | Gillissen |
D544957 | June 19, 2007 | Bloc |
D610253 | February 16, 2010 | Kawamura |
D610678 | February 23, 2010 | Kawamura |
D624641 | September 28, 2010 | Boclet |
D697201 | January 7, 2014 | Coghill |
D699342 | February 11, 2014 | Suzuki |
9821127 | November 21, 2017 | Barber |
20100095957 | April 22, 2010 | Corbacho |
20130056557 | March 7, 2013 | Felder |
20140263456 | September 18, 2014 | Barber |
20140263457 | September 18, 2014 | Barber |
Patent History
Patent number: D860435
Type: Grant
Filed: Sep 13, 2017
Date of Patent: Sep 17, 2019
Assignee: JANSSEN PHARMACEUTICA NV (Beerse)
Inventors: Jingli Wang (San Jose, CA), Michael Cannamela (Atlantic Highlands, NJ), Hong Yan (Pleasanton, CA), Rochelle Kleinberg (New York, NY)
Primary Examiner: Karen E Kearney
Assistant Examiner: Lilyana Bekic
Application Number: 29/617,294
Type: Grant
Filed: Sep 13, 2017
Date of Patent: Sep 17, 2019
Assignee: JANSSEN PHARMACEUTICA NV (Beerse)
Inventors: Jingli Wang (San Jose, CA), Michael Cannamela (Atlantic Highlands, NJ), Hong Yan (Pleasanton, CA), Rochelle Kleinberg (New York, NY)
Primary Examiner: Karen E Kearney
Assistant Examiner: Lilyana Bekic
Application Number: 29/617,294
Classifications